explore -WSS

explore

author：hotspot 2025-09-03 05:39:56 - browse：19328

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is pivoting its business and cutting hundreds of jobs, including a C-suite role.

The company announced Tuesday that it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift away from its contract manufacturing services business. The current chief operating officer, Adam Havey, will leave the company on Sept. 30.

Instead, Emergent will focus on producing Narcan nasal spray and other products. The overdose reversal medicine became available as an over-the-counter medicine earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

WSS

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

AI gets buy

Senate panel to vote on hospitals, PBMs, prisoner care

Top private equity targets in 2023: cardiology, clinical trials, lasers

Testing for cancer recurrence creates a new limbo for patients

Readout LOUD: Venture capital, Gilead, and more M&A

knowledge

explore

Wikipedia

Cancer drug shortages should be causing more outrage

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Heart attack and stroke risk calculators need revising

Readout LOUD: Venture capital, Gilead, and more M&A

Bright Health sells Medicare Advantage business to Molina

Top private equity targets in 2023: cardiology, clinical trials, lasers

Heart attack and stroke risk calculators need revising

Meta's Zuckerberg and Chan on track to put $50 billion into science

Tori Bowie and the unacceptable rates of Black maternal death

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

Johnson & Johnson sued for allegedly overpaying for workers' drugs

AI gets buy

Why Novartis is going to walk from its acquisition of MorphoSys

Chimpanzees, like humans and whales, get menopause: Study

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Unique patient identifier: Experts argue the benefits, pitfalls

hotspot

explore

knowledge

focus